.After antibody-drug conjugate (ADC) specialist Seagen was actually offered to Pfizer in 2014 for a ...
.On the heels of a period 3 succeed that fell short to impress clients, Ironwood Pharmaceuticals is ...
.Do not stop Monte Rosa Therapies now. The Boston-based biotech is enjoying after authorizing a cope...
.Accept to recently's Chutes & Ladders, our summary of substantial management hirings, firings an...
.Commemorating his business's upsized initial public offering (IPO), Septerna chief executive office...
.AbbVie has come back to the source of its own antipsychotic powerhouse Vraylar seeking yet another ...
.GenSight Biologics is full weeks away from losing funds. Once again. The biotech just has adequate ...
.Monopar Rehabs is recovering a drug from the scrap heap of AstraZeneca's uncommon disease pipeline....
.Along with new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of pr...
.After developing a gene treatment partnership along with Dyno Therapeutics in 2020, Roche is back f...